Article
EGFR exon 20 insertion mutations in Chinese advanced non-small cell lung cancer patients: Molecular heterogeneity and treatment outcome from nationwide real-world study.
Lung cancer (Amsterdam, Netherlands) - 1 Jul 2020
Yang Guangjian, Li Jun, Xu Haiyan, Yang Yaning, Yang Lu, Xu Fei, Xia Bing, Zhu Viola W, Nagasaka Misako, Yang Yan, Li Yapin, Qiu Weini, Ying Jianming, Ou Sai-Hong Ignatius, Wang Yan
Abstract excerpt
OBJECTIVES: To describe the treatment patterns and outcomes of Chinese non-small cell lung cancer (NSCLC) patients with epidermal growth factor receptor (EGFR) exon 20 insertion (ex20ins) mutations in real-world as EGFR ex20ins consist of a diverse group of mutations with limited information on the clinical outcome of these patients treated with chemotherapy or EGFR tyrosine kinase inhibitors (TKIs). MATERIALS...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.